Boundless Bio

Board room C-suite meeting contract
Biotech

Boundless drops clinical-stage cancer drug, shakes up C-suite

Boundless Bio's freshman year on the public markets hasn’t been easy, with layoffs in the summer followed by dropping a clinical-stage candidate
James Waldron Dec 13, 2024 7:30am
3D rendering of chromosomes and circular extrachromosomal DNA

Drug shrinks tumors in mice by targeting extrachromosomal DNA

Nov 6, 2024 12:50pm
layoffs cuts workforce reduction chairs boxes fired

Boundless Bio makes 'modest' layoffs 5 months after $100M IPO

Aug 13, 2024 4:27am
Photo of Wall Street street sign with american flags in the background

Boundless boldly goes public with $100M IPO

Mar 28, 2024 7:10am
crocus spring flowers bloom blossom purple violet

Boundless Bio eyes $88M offering as spring IPO market blooms

Mar 21, 2024 8:50am
Photo of a sheep leaping forward seemingly off a rock elevated above other sheep

Boundless Bio bumps IPO market back to life

Mar 6, 2024 5:20pm